SG
CH EN SG MY

Advanced injection techniques of poly-L-lactic acid: a case-based presentation

WM. PHILIP WERSCHLER

This article presents a patient who illustrates the current treatment techniques that optimize the efficacy and tolerability of poly-L-lactic acid.

The biological basis for poly-L-lactic acid-induced augmentation

Philipp Stein , Olga Vitavska , Peter Kind , Willi Hoppe , Helmut Wieczorek , Nanna Y. Schurer

PLLA-induced augmentation is most likely based on capsule formation orchestrating macrophages, (myo-)fibroblasts, and collagen type I and III fibres. We observed considerably slower degradation of PLLA particles than described previously. Thus PLLA partic

Adverse Reactions to Dermal Fillers: Review

NICHOLAS J. LOWE, MD, FRCP, FACS , C. ANNE MAXWELL, MB, CHB, AND RICKIE PATNAIK, MD

Different injectable products have highly divergent properties, associated risks, and injection requirements. The der- masurgeon should be suitably experienced to select and use these products correctly.

Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correctio

M. Y. Hyun, Y. Lee, Y. A. No, K. H. Yoo, M. N. Kim, C. K. Hong, S. E. Chang, C. H. Won and B. J. Kim

At week 24, mean improvement in WSRS from baseline was 2.09  0.68 for the PLA side and 1.54  0.65 for the HA side. Both injections were well toler- ated, and the adverse reactions were mild and transient in most cases. PLA provides noninferior efficac
0.031752s